Skip to main content

Table 4 Correlations of ESA dose and ERI with log CD133/Flk1+ EPC, according to ESA type

From: Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients

 

ESA dose versus log CD133/Flk1+ EPC

ERI versus log CD133/Flk1+ EPC

r

p

r

p

All subjects (n = 101)

 − 0.206

0.039

 − 0.207

0.037

Epoetin (n = 31)

 − 0.176

0.343

 − 0.157

0.398

DA (n = 65)

 − 0.194

0.122

 − 0.213

0.088

CERA (n = 5)

 − 0.300

0.624

 − 0.600

0.285

  1. Correlations of ESA dose and ERI with log CD133/Flk1+ EPC were analyzed by Spearman’s method. P values in bold indicate statistical significance
  2. DA, darbepoetin alpha; CERA, continuous erythropoietin receptor activator
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us